These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15723523)

  • 1. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
    Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data.
    Ding H; Yang Y; Zhang J; Wu J; Liu H; Shi Y
    Proteins; 2005 Dec; 61(4):1050-8. PubMed ID: 16224784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
    Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
    PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
    Sekiyama N; Arita K; Ikeda Y; Hashiguchi K; Ariyoshi M; Tochio H; Saitoh H; Shirakawa M
    Proteins; 2010 May; 78(6):1491-502. PubMed ID: 20077568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
    Giraud MF; Desterro JM; Naismith JH
    Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
    J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
    Tatham MH; Chen Y; Hay RT
    Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
    Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
    Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
    Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of SUMO from Trypanosoma brucei and its interaction with Ubc9.
    Shang Q; Xu C; Zhang J; Zhang X; Tu X
    Proteins; 2009 Jul; 76(1):266-9. PubMed ID: 19343802
    [No Abstract]   [Full Text] [Related]  

  • 15. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9.
    Mohideen F; Capili AD; Bilimoria PM; Yamada T; Bonni A; Lima CD
    Nat Struct Mol Biol; 2009 Sep; 16(9):945-52. PubMed ID: 19684601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a substrate recognition site on Ubc9.
    Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
    J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.